This Nephrology and Urology Devices market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.
The nephrology and urology devices market size has grown strongly in recent years. It will grow from $56.32 billion in 2024 to $60.28 billion in 2025 at a compound annual growth rate (CAGR) of 7%. The growth in the historic period can be attributed to aging population, high prevalence of urological disorders, chronic kidney disease (ckd) management, healthcare reimbursement.
The nephrology and urology devices market size is expected to see strong growth in the next few years. It will grow to $77.1 billion in 2029 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to telemedicine and remote consultations, personalized medicine, value-based care, emerging markets growth, artificial intelligence (AI) integration. Major trends in the forecast period include minimally invasive procedures, remote monitoring and telehealth, 3D printing of urological implants, smart catheters and drainage devices, home dialysis solutions.
The increasing prevalence of kidney and urinary tract diseases is set to drive the growth of the nephrology and urology devices market in the future. These health issues affect various components of the urinary system, including the kidneys, ureters, bladder, and urethra. Medical devices in the field of nephrology and urology play a crucial role in addressing conditions like chronic kidney disease (CKD) and end-stage renal disease (ESRD). For example, in June 2023, Kidney Research UK reported that over 7.19 million people in the UK were affected by chronic kidney disease, which accounts for more than 10% of the UK's population. The number is projected to increase to 7.61 million people by 2033. Consequently, the rising incidence of kidney and urinary tract diseases is expected to be a significant driver of growth in the nephrology and urology devices market.
The increase in the patient population, driven by the growing global elderly demographic, has significantly contributed to the historical growth of the nephrology and urology devices market. For instance, in January 2024, the Population Reference Bureau (PRB), a US-based non-profit organization, reported that the number of Americans aged 65 and older is projected to grow from 58 million in 2022 to 82 million by 2050, marking a 47% increase. Furthermore, the proportion of this age group within the total population is expected to rise from 17% to 23%. With the U.S. population now at its oldest in history, the growing geriatric demographic is driving increased demand for medical care and contributing to higher healthcare expenditures.
Leading companies in the nephrology and urology devices market are leveraging advanced technologies, such as artificial intelligence (AI), to improve diagnostic accuracy and expand treatment options for patients. AI tools, which encompass software applications and systems utilizing machine learning algorithms, data analytics, and other advanced computational techniques, are designed to enhance healthcare outcomes. For example, in April 2024, Dornier MedTech GmbH, a Germany-based medical device company, launched UroGPT. This AI-powered tool, designed specifically for kidney stone patients, uses natural language processing to provide real-time, personalized support. Acting as a chatbot, UroGPT interprets patient queries about kidney stones and delivers tailored, easy-to-understand responses, addressing patients' concerns and anxieties effectively.
Major companies in the nephrology and urology markets are actively investing in research and development of advanced technologies to expand their product portfolios and enhance their market share. One such advancement is the development of ambulatory peritoneal dialysis machines, which provide patients with the flexibility to perform dialysis at home or while on the move. This innovation offers convenience and mobility to patients in managing their condition. In June 2023, LiberDi Ltd., an Israeli medical device company, gained FDA approval for a continuous ambulatory peritoneal dialysis machine. This system is designed to offer patients ease of use, mobility, automatic catheter connection flush technology, and continuous monitoring, allowing them to conveniently carry out their daily dialysis routines at home or in various settings.
Major companies operating in the nephrology and urology devices market include Baxter International Inc., Fresenius Medical Care AG & Co. KGaA, Cook Group Incorporated, B. Braun Group, C. R. Bard Inc., Boston Scientific Corporation, Coloplast Private Limited, Convatec Group PLC, Hollister Incorporated, Teleflex Incorporated, J and M Urinary Catheters LLC, NxStage Medical Inc., Olympus Corporation, Stryker Corporation, Karl Storz Se & Co. KG, Richard Wolf GmbH, Becton, Dickinson and Company, Terumo Corporation, Uromed Kurt Drews KG, Urocare Products Inc., Urotech GmbH, Wellspect Healthcare AB, Medtronic PLC, Dornier MedTech GmbH, Nikkiso Co. Ltd., Siemens Healthineers AG, Nipro Corporation, Urologix LLC, Johnson & Johnson, Abbott Laboratories.
Nephrology and urology devices play a crucial role in the diagnosis and treatment of kidney and genitourinary diseases.
The primary categories of nephrology and urology devices encompass dialysis devices and equipment, urinary stone treatment devices and equipment, urinary incontinence and pelvic organ prolapse devices and equipment, benign prostatic hyperplasia (BPH) treatment devices and equipment, as well as endoscopy devices and equipment. Dialysis devices and equipment are instrumental in the dialysis process, functioning as artificial kidneys to filter a patient's blood, eliminating excess water and waste products when kidney function is impaired. Expenditure for these devices can be both public and private. These devices and equipment utilize instruments/equipment and disposables, serving a wide range of end-users including hospitals and clinics, diagnostic laboratories, and others.
The nephrology and urology devices market research report is one of a series of new reports that provides nephrology and urology devices market statistics, including nephrology and urology devices industry global market size, regional shares, competitors with a nephrology and urology devices market share, detailed nephrology and urology devices market segments, market trends and opportunities, and any further data you may need to thrive in the nephrology and urology devices industry. This nephrology and urology devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
North America was the largest region in the global nephrology and urology devices market in 2024. Asia-Pacific was the second largest region in the global nephrology and urology devices market. The regions covered in the nephrology and urology devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the nephrology and urology devices market report are Australia, China, India, Indonesia, Japan, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, France, Germany, UK, Austria, Belgium, Denmark, Finland, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
The nephrology and urology devices market consist of sales of instruments such as ureteral catheters, PCN catheters, urinary stents, stone baskets, urology guidewires, and renal dilators that are used to treat kidney and genitourinary diseases. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The nephrology and urology devices market size has grown strongly in recent years. It will grow from $56.32 billion in 2024 to $60.28 billion in 2025 at a compound annual growth rate (CAGR) of 7%. The growth in the historic period can be attributed to aging population, high prevalence of urological disorders, chronic kidney disease (ckd) management, healthcare reimbursement.
The nephrology and urology devices market size is expected to see strong growth in the next few years. It will grow to $77.1 billion in 2029 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to telemedicine and remote consultations, personalized medicine, value-based care, emerging markets growth, artificial intelligence (AI) integration. Major trends in the forecast period include minimally invasive procedures, remote monitoring and telehealth, 3D printing of urological implants, smart catheters and drainage devices, home dialysis solutions.
The increasing prevalence of kidney and urinary tract diseases is set to drive the growth of the nephrology and urology devices market in the future. These health issues affect various components of the urinary system, including the kidneys, ureters, bladder, and urethra. Medical devices in the field of nephrology and urology play a crucial role in addressing conditions like chronic kidney disease (CKD) and end-stage renal disease (ESRD). For example, in June 2023, Kidney Research UK reported that over 7.19 million people in the UK were affected by chronic kidney disease, which accounts for more than 10% of the UK's population. The number is projected to increase to 7.61 million people by 2033. Consequently, the rising incidence of kidney and urinary tract diseases is expected to be a significant driver of growth in the nephrology and urology devices market.
The increase in the patient population, driven by the growing global elderly demographic, has significantly contributed to the historical growth of the nephrology and urology devices market. For instance, in January 2024, the Population Reference Bureau (PRB), a US-based non-profit organization, reported that the number of Americans aged 65 and older is projected to grow from 58 million in 2022 to 82 million by 2050, marking a 47% increase. Furthermore, the proportion of this age group within the total population is expected to rise from 17% to 23%. With the U.S. population now at its oldest in history, the growing geriatric demographic is driving increased demand for medical care and contributing to higher healthcare expenditures.
Leading companies in the nephrology and urology devices market are leveraging advanced technologies, such as artificial intelligence (AI), to improve diagnostic accuracy and expand treatment options for patients. AI tools, which encompass software applications and systems utilizing machine learning algorithms, data analytics, and other advanced computational techniques, are designed to enhance healthcare outcomes. For example, in April 2024, Dornier MedTech GmbH, a Germany-based medical device company, launched UroGPT. This AI-powered tool, designed specifically for kidney stone patients, uses natural language processing to provide real-time, personalized support. Acting as a chatbot, UroGPT interprets patient queries about kidney stones and delivers tailored, easy-to-understand responses, addressing patients' concerns and anxieties effectively.
Major companies in the nephrology and urology markets are actively investing in research and development of advanced technologies to expand their product portfolios and enhance their market share. One such advancement is the development of ambulatory peritoneal dialysis machines, which provide patients with the flexibility to perform dialysis at home or while on the move. This innovation offers convenience and mobility to patients in managing their condition. In June 2023, LiberDi Ltd., an Israeli medical device company, gained FDA approval for a continuous ambulatory peritoneal dialysis machine. This system is designed to offer patients ease of use, mobility, automatic catheter connection flush technology, and continuous monitoring, allowing them to conveniently carry out their daily dialysis routines at home or in various settings.
Major companies operating in the nephrology and urology devices market include Baxter International Inc., Fresenius Medical Care AG & Co. KGaA, Cook Group Incorporated, B. Braun Group, C. R. Bard Inc., Boston Scientific Corporation, Coloplast Private Limited, Convatec Group PLC, Hollister Incorporated, Teleflex Incorporated, J and M Urinary Catheters LLC, NxStage Medical Inc., Olympus Corporation, Stryker Corporation, Karl Storz Se & Co. KG, Richard Wolf GmbH, Becton, Dickinson and Company, Terumo Corporation, Uromed Kurt Drews KG, Urocare Products Inc., Urotech GmbH, Wellspect Healthcare AB, Medtronic PLC, Dornier MedTech GmbH, Nikkiso Co. Ltd., Siemens Healthineers AG, Nipro Corporation, Urologix LLC, Johnson & Johnson, Abbott Laboratories.
Nephrology and urology devices play a crucial role in the diagnosis and treatment of kidney and genitourinary diseases.
The primary categories of nephrology and urology devices encompass dialysis devices and equipment, urinary stone treatment devices and equipment, urinary incontinence and pelvic organ prolapse devices and equipment, benign prostatic hyperplasia (BPH) treatment devices and equipment, as well as endoscopy devices and equipment. Dialysis devices and equipment are instrumental in the dialysis process, functioning as artificial kidneys to filter a patient's blood, eliminating excess water and waste products when kidney function is impaired. Expenditure for these devices can be both public and private. These devices and equipment utilize instruments/equipment and disposables, serving a wide range of end-users including hospitals and clinics, diagnostic laboratories, and others.
The nephrology and urology devices market research report is one of a series of new reports that provides nephrology and urology devices market statistics, including nephrology and urology devices industry global market size, regional shares, competitors with a nephrology and urology devices market share, detailed nephrology and urology devices market segments, market trends and opportunities, and any further data you may need to thrive in the nephrology and urology devices industry. This nephrology and urology devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
North America was the largest region in the global nephrology and urology devices market in 2024. Asia-Pacific was the second largest region in the global nephrology and urology devices market. The regions covered in the nephrology and urology devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the nephrology and urology devices market report are Australia, China, India, Indonesia, Japan, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, France, Germany, UK, Austria, Belgium, Denmark, Finland, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
The nephrology and urology devices market consist of sales of instruments such as ureteral catheters, PCN catheters, urinary stents, stone baskets, urology guidewires, and renal dilators that are used to treat kidney and genitourinary diseases. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Executive Summary
Nephrology and Urology Devices Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on nephrology and urology devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 50 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for nephrology and urology devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The nephrology and urology devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include: the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Type: Dialysis Devices and Equipment; Urinary Stone Treatment Devices and Equipment; Urinary Incontinence and Pelvic Organ Prolapse Devices and Equipment; Benign Prostatic Hyperplasia (BPH) Treatment Devices and Equipment; Endoscopy Devices and Equipment2) By End User: Hospitals and Clinics; Diagnostic Laboratories; Other End Users
3) By Type of Expenditure: Public; Private
4) By Product: Instruments/Equipment; Disposables
Subsegments:
1) By Dialysis Devices and Equipment: Hemodialysis Machines; Peritoneal Dialysis Machines; Dialyzers (Hemodialysis Filters); Dialysis Concentrates; Dialysis Catheters2) By Urinary Stone Treatment Devices and Equipment: Lithotripters (Shock Wave Lithotripsy Machines); Laser Lithotripters; Ureteroscopes; Nephroscopes; Stone Removal Catheters
3) By Urinary Incontinence and Pelvic Organ Prolapse Devices and Equipment: Urinary Incontinence Devices (Urinary Catheters, External Urinary Collection Devices); Pelvic Floor Electrical Stimulation Devices; Vaginal Inserts; Slings for Pelvic Organ Prolapse
4) By Benign Prostatic Hyperplasia (BPH) Treatment Devices and Equipment: Prostate Stents; Laser BPH Devices; Transurethral Resection of the Prostate (TURP) Devices; Urolift Systems; GreenLight Laser Systems
5) By Endoscopy Devices and Equipment: Cystoscopes; Ureteroscopes; Renal Biopsy Instruments; Laparoscopes; Rigid and Flexible Endoscopes
Key Companies Mentioned: Baxter International Inc.; Fresenius Medical Care AG & Co. KGaA; Cook Group Incorporated; B. Braun Group; C. R. Bard Inc.
Countries: Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
The major companies featured in this Nephrology and Urology Devices market report include:- Baxter International Inc.
- Fresenius Medical Care AG & Co. KGaA
- Cook Group Incorporated
- B. Braun Group
- C. R. Bard Inc.
- Boston Scientific Corporation
- Coloplast Private Limited
- Convatec Group plc
- Hollister Incorporated
- Teleflex Incorporated
- J and M Urinary Catheters LLC
- NxStage Medical Inc.
- Olympus Corporation
- Stryker Corporation
- Karl Storz Se & Co. KG
- Richard Wolf GmbH
- Becton, Dickinson and Company
- Terumo Corporation
- Uromed Kurt Drews KG
- Urocare Products Inc.
- Urotech GmbH
- Wellspect Healthcare AB
- Medtronic plc
- Dornier MedTech GmbH
- Nikkiso Co. Ltd.
- Siemens Healthineers AG
- Nipro Corporation
- Urologix LLC
- Johnson & Johnson
- Abbott Laboratories
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 400 |
| Published | April 2025 |
| Forecast Period | 2025 - 2029 |
| Estimated Market Value ( USD | $ 60.28 Billion |
| Forecasted Market Value ( USD | $ 77.1 Billion |
| Compound Annual Growth Rate | 6.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 31 |
